1. Home
  2. ARQT vs PUMP Comparison

ARQT vs PUMP Comparison

Compare ARQT & PUMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • PUMP
  • Stock Information
  • Founded
  • ARQT 2016
  • PUMP 2007
  • Country
  • ARQT United States
  • PUMP United States
  • Employees
  • ARQT N/A
  • PUMP N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • PUMP Oilfield Services/Equipment
  • Sector
  • ARQT Health Care
  • PUMP Energy
  • Exchange
  • ARQT Nasdaq
  • PUMP Nasdaq
  • Market Cap
  • ARQT 1.1B
  • PUMP 938.7M
  • IPO Year
  • ARQT 2020
  • PUMP 2017
  • Fundamental
  • Price
  • ARQT $13.08
  • PUMP $11.06
  • Analyst Decision
  • ARQT Strong Buy
  • PUMP Buy
  • Analyst Count
  • ARQT 5
  • PUMP 7
  • Target Price
  • ARQT $17.00
  • PUMP $11.17
  • AVG Volume (30 Days)
  • ARQT 2.0M
  • PUMP 1.9M
  • Earning Date
  • ARQT 02-25-2025
  • PUMP 02-19-2025
  • Dividend Yield
  • ARQT N/A
  • PUMP N/A
  • EPS Growth
  • ARQT N/A
  • PUMP N/A
  • EPS
  • ARQT N/A
  • PUMP N/A
  • Revenue
  • ARQT $138,708,000.00
  • PUMP $1,471,508,000.00
  • Revenue This Year
  • ARQT $209.03
  • PUMP N/A
  • Revenue Next Year
  • ARQT $49.00
  • PUMP N/A
  • P/E Ratio
  • ARQT N/A
  • PUMP N/A
  • Revenue Growth
  • ARQT 182.84
  • PUMP N/A
  • 52 Week Low
  • ARQT $3.59
  • PUMP $6.54
  • 52 Week High
  • ARQT $16.20
  • PUMP $11.17
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 46.24
  • PUMP 78.70
  • Support Level
  • ARQT $12.61
  • PUMP $10.51
  • Resistance Level
  • ARQT $14.36
  • PUMP $11.17
  • Average True Range (ATR)
  • ARQT 0.98
  • PUMP 0.41
  • MACD
  • ARQT -0.32
  • PUMP 0.10
  • Stochastic Oscillator
  • ARQT 13.09
  • PUMP 94.86

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About PUMP ProPetro Holding Corp.

ProPetro Holding Corp is a Texas-based oilfield services company. It provides hydraulic fracturing, wireline, and other complementary services to oil and gas companies engaged in the exploration and production of North American oil and natural gas resources. The company focused on the Permian Basin. The operating segments of the company are hydraulic fracturing which generates key revenue, wireline, cementing, and coiled tubing.

Share on Social Networks: